Drick DRK-900 Gas Chromatograph with Headspace Sampler

Overview

The Drick DRK-900 Gas Chromatograph with Integrated Headspace Sampler is a dedicated analytical platform engineered for precise quantification of residual ethylene oxide (EO) in sterilized medical devices, pharmaceutical packaging, and polymeric materials. It operates on the fundamental principle of gas chromatography coupled with static headspace sampling — a method standardized under ISO 10993-7 for cytotoxicity evaluation of EO residuals and aligned with USP Chapter <1208> “Sterility Assurance for Ethylene Oxide–Sterilized Products.” The system separates volatile EO from solid or semi-solid matrices via thermal equilibration in sealed vials, followed by automated injection of the vapor phase into a capillary column (e.g., DB-624 or equivalent polar stationary phase). Detection is achieved using a flame ionization detector (FID), delivering linear response across the clinically relevant range of 0.1–50 µg/g with high reproducibility (RSD < 3% at 10 µg/g, n = 6). Its robust architecture supports routine QC/QA workflows in GLP-compliant laboratories, including those undergoing FDA 21 CFR Part 11 audit readiness.

Key Features

• Integrated headspace autosampler with 12-position vial capacity and programmable temperature control (30–200 °C) for precise equilibration kinetics
• Programmable oven with ramp rates up to 40 °C/min and isothermal stability ±0.1 °C for optimized EO elution profile resolution
• FID detector with auto-ignition, digital signal processing, and detection limit ≤ 0.02 ng carbon/sec (as methane)
• Embedded 7-inch touchscreen interface supporting method storage, real-time chromatogram display, and basic peak integration
• Modular column compartment accommodating standard 0.25–0.53 mm ID fused-silica capillaries (up to 30 m length)
• Gas control system with electronic pressure regulation (EPC) for carrier gas (N₂ or He), air, and hydrogen supply

Sample Compatibility & Compliance

The DRK-900 accommodates diverse sample formats including pre-packed EO test kits, sterilized catheters, syringe barrels, IV bags, filter membranes, and lyophilized vial stoppers. Sample preparation follows ISO 10993-7 Annex B protocols: specimens are weighed into 20-mL headspace vials, spiked with internal standard (e.g., d₄-ethylene oxide), sealed with crimp caps, and equilibrated at 60 °C for 60 min. The instrument meets essential requirements for medical device validation per EN ISO 11135 and supports documentation traceability for FDA 510(k) submissions. While not certified to IEC 61010-1 out-of-the-box, its electrical safety design conforms to GB 4793.1 (Chinese national equivalent), and optional CE marking is available upon third-party testing.

Software & Data Management

Data acquisition and reporting are managed via Drick ChromaView™ PC software (Windows 10/11 compatible), which provides full audit trail functionality compliant with ALCOA+ principles. The software supports user-defined report templates, electronic signatures, version-controlled method libraries, and automatic calculation of residual EO concentration using internal standard calibration curves. Raw data files (.cdf) are exportable in ASTM E1319-compliant format for long-term archival. For regulated environments, optional 21 CFR Part 11 modules include role-based access control, electronic signature enforcement, and immutable audit logs — all validated per GAMP 5 guidelines.

Applications

• Quantitative EO residue testing in Class II/III medical devices prior to market release
• Stability studies assessing EO desorption kinetics from polymer-based implants
• Validation of EO sterilization cycle parameters (time, temperature, humidity, gas concentration)
• QC screening of pharmaceutical primary packaging (e.g., blister foils, rubber stoppers)
• Environmental monitoring of EO off-gassing in cleanroom storage areas
• Research applications in polymer degradation and sterilant interaction mechanisms

FAQ

Does the DRK-900 comply with ISO 10993-7 for medical device testing?
Yes — the system’s headspace methodology, calibration protocol, and detection sensitivity align with the quantitative requirements specified in ISO 10993-7:2019 Annex B.
Can it be used for other volatile organic compounds beyond EO?
Yes — with appropriate column selection and method development, it supports analysis of residual solvents (e.g., chloroform, methanol, acetone) per ICH Q3C guidelines.
Is remote operation or network integration supported?
Standard configuration includes USB and RS-232 connectivity; Ethernet and LIMS integration (via ASTM E1319 or HL7) are available as factory-installed options.
What maintenance intervals are recommended for routine FID operation?
FID jet cleaning and detector optimization are advised every 200 injections or quarterly, whichever occurs first; column trimming and bake-out should follow ISO/IEC 17025 internal SOPs.
Are consumables such as headspace vials and septa supplied by Drick?
Yes — certified 20-mL crimp-top vials, PTFE/silicone septa, and GC-grade standards (including EO and d₄-EO) are available through Drick’s global distribution network.